Coronavirus

Publications

2020

Gillot C, Douxfils J, Cadrobbi J, Laffineur K, Dogné JM, Elsen M, Eucher C, Melchionda S, Modaffarri É, Tré-Hardy M, Favresse J. An Original ELISA-Based Multiplex Method for the Simultaneous Detection of 5 SARS-CoV-2 IgG Antibodies Directed against Different Antigens. J Clin Med. 2020 Nov 21;9(11):E3752.

Hardy M, Michaux I, Lessire S, Douxfils J, Dogné JM, Bareille M, Horlait G, Bulpa P, Chapelle C, Laporte S, Testa S, Jacqmin H, Lecompte T, Dive A, Mullier F. Prothrombotic hemostasis disturbances in patients with severe COVID-19: Individual daily data. Data Brief. 2020 Dec;33:106519.

Favresse J, Cadrobbi J, Eucher C, Elsen M, Laffineur K, Dogné JM, Douxfils J. Clinical performances of three fully automated anti-SARS-CoV-2 immunoassays targeting the nucleocapsid or spike proteins. J Med Virol. 2020 Nov 17.

Hardy M, Michaux I, Lessire S, Douxfils J, Dogné JM, Bareille M, Horlait G, Bulpa P, Chapelle C, Laporte S, Testa S, Jacqmin H, Lecompte T, Dive A, Mullier F. Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study. Thromb Res. 2020 Oct 24;197:20-23.

Vanwambeke SO, Linard C, Gilbert M, Dellicour S. SARS-CoV-2 emergence and diffusion: a new disease manifesting human-environment interactions and a global geography of health. Curr Opin Environ Sustain. 2020 Oct 27.

Barakat T, Muylkens B, Su BL. Is Particulate Matter of Air Pollution a Vector of Covid-19 Pandemic? Matter. 2020 Oct 7;3(4):977-980.

Hardy M, Douxfils J, Dogné JM, Lessire S, Chatelain B, Testa S, Gouin-Thibault I, Gruel Y, Lecompte T, Mullier F. Management of the thrombotic risk associated with COVID-19: what is the role of the hemostasis laboratory? Ann Biol Clin (Paris). 2020 Oct 1;78(5):471-481.

Thémans P, Belkhir L, Dauby N, Yombi JC, De Greef J, Delongie KA, Vandeputte M, Nasreddine R, Wittebole X, Wuillaume F, Lescrainier C, Verlinden V, Kiridis S, Dogné JM, Hamdani J, Wallemacq P, Musuamba FT. Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients: Implications for Dose Optimization. Eur J Drug Metab Pharmacokinet. 2020 Sep 23.

Yang J, Petitjean SJL, Koehler M, Zhang Q, Dumitru AC, Chen W, Derclaye S, Vincent SP, Soumillion P, Alsteens D. Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor. Nat Commun. 2020 Sep 11;11(1):4541.

Hardy M, Lecompte T, Douxfils J, Lessire S, Dogné JM, Chatelain B, Testa S, Gouin-Thibault I, Gruel Y, Medcalf RL, Ten Cate H, Lippi G, Mullier F. Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory. Thromb J. 2020 Sep 7;18:17.

Candellier A, Scohy A, Gillet N, Muylkens B, Morelle J, Belkhir L, Coupeau D, Jadoul M, Goffin É. Absence of SARS-CoV-2 in the effluent of peritoneal dialysis patients. Perit Dial Int. 2020 Sep;40(5):499-503.

Coupeau D, Burton N, Lejeune N, Loret S, Petit A, Pejakovic S, Poulain F, Bonil L, Trozzi G, Wiggers L, Willemart K, André E, Laenen L, Cuypers L, Van Ranst M, Bogaerts P, Muylkens B, Gillet NA. SARS-CoV-2 Detection for Diagnosis Purposes in the Setting of a Molecular Biology Research Lab. Methods Protoc. 2020 Aug 18;3(3):E59.

Mairesse A, Favresse J, Eucher C, Elsen M, Tré-Hardy M, Haventith C, Gruson D, Dogné JM, Douxfils J, Göbbels P. High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodies. Clin Biochem. 2020 Aug 25:S0009-9120(20)30817-1.

Hardy M, Douxfils J, Bareille M, Lessire S, Gouin-Thibault I, Fontana P, Lecompte T, Mullier F. Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance and their limitations. J Thromb Haemost. 2020 Aug 13:10.1111/jth.15061.

Blairon L, Mokrane S, Wilmet A, Dessilly G, Kabamba-Mukadi B, Beukinga I, Tré-Hardy M. Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak. J Infect. 2020 Jul 30:S0163-4453(20)30514-4.

Thémans P, Dauby N, Schrooyen L, Lebout F, Delforge M, Nasreddine R, Libois A, Payen MC, Konopnicki D, Wuillaume F, Lescrainier C, Verlinden V, Dogné JM, Hamdani J, Musuamba FT. Model informed dosing of hydroxycholoroquine in COVID-19 patients: Learnings from the recent experience, remaining uncertainties and gaps. Br J Clin Pharmacol. 2020 Jun 19.

Tré-Hardy M, Wilmet A, Beukinga I, Favresse J, Dogné JM, Douxfils J, Blairon L. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA and IgM antibodies. J Med Virol. 2020 Jul 15.

Favresse J, Eucher C, Elsen M, Laffineur K, Dogné JM, Douxfils J. Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study. Clin Chem Lab Med. 2020 Sep 25;58(10):e193-e196.

Favresse J, Eucher C, Elsen M, Graux C, Goebels P, Laffineur K, Nicolas JB, Dogné JM, Douxfils J. Unexpected kinetics of anti-SARS-CoV-2 total antibodies in two patients with chronic lymphocytic leukemia. Br J Haematol. 2020 Jun 17.

Favresse J, Eucher C, Elsen M, Tré-Hardy M, Dogné JM, Douxfils J. Clinical performance of the Elecsys electrochemiluminescent immunoassay for the detection of SARS-CoV-2 total antibodies. Clin Chem. 2020 Aug 1;66(8):1104-1106.

Blairon L, Wilmet A, Beukinga I, Tré-Hardy M. Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods: Experiences of a general hospital. J Clin Virol. 2020 May 30;129:104472.

Tré-Hardy M, Wilmet A, Beukinga I, Dogné JM, Douxfils J, Blairon L. Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody. Clin Chem Lab Med. 2020 Jul 28;58(8):1357-1364.

Tré-Hardy M, Blairon L, Wilmet A, Beukinga I, Malonne H, Dogné JM, Douxfils J. The role of serology for COVID-19 control: Population, kinetics and test performance do matter. J Infect. 2020 May 15:S0163-4453(20)30297-8.